Active Ingredient History

  • Now
Clevudine (INN) is an antiviral drug for the treatment of hepatitis B (HBV). It is already approved for HBV in South Korea and the Philippines. It is marketed by Bukwang Pharmaceuticals in South Korea under the tradenames Levovir and Revovir.   Wikipedia

  • SMILES: CC1=CN([C@H]2O[C@@H](CO)[C@H](O)[C@H]2F)C(=O)NC1=O
  • Mol. Mass: 260.22
  • ALogP: -1.57
  • ChEMBL Molecule:
More Chemistry
1-(2-fluoro-2-deoxy-beta-arabinofuranosyl)thymine | 1-(2-fluoro-2-deoxy-beta-d-arabinofuranosyl)thymine | 1-(2-fluoro-5-methyl-beta,l-arabinofuranosyl)uracil | 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-5-methyl- | 2'-deoxy-2'-fluoroarabinofuranosylthymine | 2'-fluoro-1-beta-arabinofuranosyl-5-methyluracil | 2'-fluoro-5-methyl-1-beta-arabinosyluracil | 2'-fluoro-5-methyl-1-beta-d-arabinofuranosyluracil | 2'-fluoro-5-methylarabinosyluracil | 2'-fluoro-5-methylarabinosyluracil, 2-(14)c-labeled | 5-methyl-2'-fluoroarauracil | clevudine | d-fmau | fmau | levovir | l-fmau


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue